Basilea Pharmaceutica
BSLN.SW
#6456
Rank
NZ$0.99 B
Marketcap
$82.03
Share price
-6.44%
Change (1 day)
16.65%
Change (1 year)

Earnings for Basilea Pharmaceutica (BSLN.SW)

Earnings in 2023: NZ$21.85 Million

According to Basilea Pharmaceutica's latest financial reports the company's current earnings are NZ$0.18 Billion. In 2023 the company made an earning of NZ$21.85 Million a decrease over its 2022 earnings that were of NZ$23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Basilea Pharmaceutica from 2002 to 2023

Annual earnings

Year Earnings Change
2023NZ$21.85 M-5.02%
2022NZ$23 M-276.18%
2021-NZ$13.06 Million-55.31%
2020-NZ$29.22 Million-28%
2019-NZ$40.59 Million-27.06%
2018-NZ$55.64 Million62.13%
2017-NZ$34.32 Million-60.94%
2016-NZ$87.85 Million-19.67%
2015-NZ$0.11 Billion48.25%
2014-NZ$73.77 Million12.95%
2013-NZ$65.32 Million-35.16%
2012-NZ$0.11 Billion-5.75%
2011-NZ$0.11 Billion-152.57%
2010NZ$0.20 B-199.59%
2009-NZ$0.21 Billion-15.54%
2008-NZ$0.25 Billion22.84%
2007-NZ$0.2 Billion60.07%
2006-NZ$0.13 Billion85.69%
2005-NZ$66.2 Million-43.04%
2004-NZ$0.12 Billion47.04%
2003-NZ$79.04 Million-32.52%
2002-NZ$0.12 Billion